-
Published07/08/2026
-
Today08/09/2026
-
Deadline10/09/2026
Utilities
- indicates text translated automatically in your browsing language
LP containing natalizumab III. 2026
The subject of the public contract is the repeated supply of medicinal products containing the active substance natalizumab, meeting the requirements of SÚKL
https://www.egordion.cz/nabidkaGORDION/profil/fnol
https://www.egordion.cz/nabidkaGORDION/profil/fnol
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.